Tenaya Therapeutics TNYA
NASDAQ TNYA
$0.57 -0.04 (-6.28%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tenaya Therapeutics (TNYA) Revenue (2026)

Updated

Tenaya Therapeutics' Revenue was $1.11 million in Q2 2026, up 393.3% from the prior quarter.

Analysis

Tenaya Therapeutics (TNYA) Revenue (2026) Analysis & Trends

On a trailing twelve-month basis, Tenaya Therapeutics' Revenue was $1.34 million through Jun 30, 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.31 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 16.99 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.38 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 7.80 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.33 Bn
10 Tenaya Therapeutics 134.54 Mn 134.54 Mn - 1.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.11 Mn
Mar 31, 2026 225,000.00
API Access

Tenaya Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=TNYA&period=max&api_key=YOUR_API_KEY